低灌注强度比与血管内卒中治疗后实质血肿风险相关
这项回顾性多中心队列研究纳入2013至2021年在两家综合卒中中心接受血管内治疗的大血管闭塞患者624例,评估低灌注强度比(HIR)与实质血肿(PH)的关系。结果显示91例(14.6%)发生PH,PH+患者入院HIR中位数0.6高于PH-患者的0.4(P<0.001);多变量回归中较高HIR与PH独立相关(aOR 1.22),且较高HIR与随访影像PH均与较低的良好临床结局几率独立相关。
要点
- 624例接受血管内治疗的大血管闭塞患者中,91例(14.6%)发生实质血肿。
- PH+患者入院HIR中位数0.6高于PH-患者的0.4(P<0.001)。
- 较高HIR与PH独立相关(aOR 1.22 [95% CI 1.09-1.38];P<0.001)。
核心结论
- 入院灌注成像上较差(较高)的HIR与血管内治疗后PH发生强烈相关。
- HIR作为脑微灌注的替代指标可能反映组织对再灌注出血的易感性。
- 这一自动化且快速可得的灌注参数可能有助于评估血管内治疗后对强化医疗护理的需求。
研究设计与样本
- 回顾性多中心队列研究,纳入2013至2021年在两家综合卒中中心(德国汉堡-埃彭多夫大学医学中心和美国加利福尼亚州斯坦福大学医学院)之一接受血管内治疗的大血管闭塞患者。
- 共624例患者符合纳入标准。
- HIR在CT灌注研究上自动计算为Tmax延迟>10秒的脑体积与Tmax>6秒体积的比值。
- 再灌注出血按海德堡出血分类评估。
- 主要结局为随访影像上PH发生(PH+)或不发生(PH-);次要结局为90天改良Rankin量表评分0至2分的良好临床结局。
主要发现
- 血管内治疗后91例(14.6%)患者发生PH。
- PH+患者入院HIR中位数0.6高于PH-患者的0.4(P<0.001)。
- 多变量回归中,较高入院血糖(aOR 1.08 [95% CI 1.04-1.13];P<0.001)、广泛基线梗死定义为Alberta卒中项目早期CT评分≤5(aOR 2.48 [1.37-4.42];P=0.002)和较高HIR(aOR 1.22 [1.09-1.38];P<0.001)是血管内治疗后PH的独立决定因素。
- 较高HIR(aOR 0.83 [0.75-0.92];P<0.001)和随访影像PH(aOR 0.39 [0.18-0.80];P=0.013)均与较低的良好临床结局几率独立相关。
关键数值与推荐
- PH定义为随访影像上的实质血肿,按海德堡出血分类评估。
- 广泛基线梗死定义为Alberta卒中项目早期CT评分≤5。
- 良好临床结局定义为90天改良Rankin量表评分0至2分。
- HIR计算为Tmax延迟>10秒的脑体积除以Tmax>6秒的体积。
临床怎么用
- 作者认为,HIR作为脑微灌注的替代指标可能反映组织对再灌注出血的易感性。
- 作者认为,这一自动化且快速可得的灌注参数可能有助于评估血管内治疗后对强化医疗护理的需求。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Parenchymal hematoma (PH) is a major complication after endovascular treatment (EVT) for ischemic stroke. The hypoperfusion intensity ratio (HIR) represents a perfusion parameter reflecting arterial collateralization and cerebral microperfusion in ischemic brain tissue. We hypothesized that HIR correlates with the risk of PH after EVT. METHODS: Retrospective multicenter cohort study of patients with large vessel occlusion who underwent EVT between 2013 and 2021 at one of the 2 comprehensive stroke centers (University Medical Center Hamburg-Eppendorf, Germany and Stanford University School of Medicine, CA). HIR was automatically calculated on computed tomography perfusion studies as the ratio of brain volume with time-to-max (Tmax) delay >10 s over volume with Tmax >6 s. Reperfusion hemorrhages were assessed according to the Heidelberg Bleeding Classification. Primary outcome was PH occurrence (PH+) or absence (PH-) on follow-up imaging. Secondary outcome was good clinical outcome defined as a 90-day modified Rankin Scale score of 0 to 2. RESULTS: A total of 624 patients met the inclusion criteria. We observed PH in 91 (14.6%) patients after EVT. PH+ patients had higher HIR on admission compared with PH- patients (median, 0.6 versus 0.4; P<0.001). In multivariable regression, higher admission blood glucose (adjusted odds ratio [aOR], 1.08 [95% CI, 1.04-1.13]; P<0.001), extensive baseline infarct defined as Alberta Stroke Program Early CT Score ≤5 (aOR, 2.48 [1.37-4.42]; P=0.002), and higher HIR (aOR, 1.22 [1.09-1.38]; P<0.001) were independent determinants of PH after EVT. Both higher HIR (aOR, 0.83 [0.75-0.92]; P<0.001) and PH on follow-up imaging (aOR, 0.39 [0.18-0.80]; P=0.013) were independently associated with lower odds of achieving good clinical outcome. CONCLUSIONS: Poorer (higher) HIR on admission perfusion imaging was strongly associated with PH occurrence after EVT. HIR as a surrogate for cerebral microperfusion might reflect tissue vulnerability for reperfusion hemorrhages. This automated and quickly available perfusion parameter might help to assess the need for intensive medical care after EVT.
引用
- Winkelmeier L, Heit JJ, Adusumilli G, et al. Hypoperfusion Intensity Ratio Is Correlated With the Risk of Parenchymal Hematoma After Endovascular Stroke Treatment. Stroke. 2022. PMID: 36416127. doi:10.1161/STROKEAHA.122.040540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。